From: Identification of novel sarcoma risk genes using a two-stage genome wide DNA sequencing strategy in cancer cluster families and population case and control cohorts
Function
Percentage
Exonic
42.45
Intronic
50.74
Intergenic
0.04
Upstream/downstream
0.68
Untranslated region
4.96
Other
1.13
Exonic function
Nonsynonymous
47.61
Synonymous
50.55
Stop gain/loss
0.50
Unknown
1.35